DreamCIS Inc Total Liabilities

Latest as of September 2025: ₩60.03 Billion KRW ≈ $40.68 Million USD

DreamCIS Inc total liabilities. Based on the latest financial reports, DreamCIS Inc (223250) has total liabilities worth ₩60.03 Billion KRW (≈ $40.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 223250 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of DreamCIS Inc (2017–2024)

Total liabilities of DreamCIS Inc from 2017 to 2024. This chart illustrates how DreamCIS Inc's total liabilities have evolved over time, based on quarterly financial data.

DreamCIS Inc Competitors by Total Liabilities

The table below lists competitors of DreamCIS Inc ranked by their total liabilities.

Company Country Total Liabilities
Powertech Industrial Co Ltd
TW:3296
Taiwan NT$879.20 Million
Electrocore LLC
NASDAQ:ECOR
USA $19.85 Million
MedFirst Healthcare Services lnc
TWO:4175
Taiwan NT$5.70 Billion
Energy Transition Minerals Ltd
AU:ETM
Australia AU$6.17 Million
TV Today Network Limited
NSE:TVTODAY
India Rs2.38 Billion
Kron Telekomunikasyon Hizmetleri AS
IS:KRONT
Turkey TL402.17 Million
Pinar Sut Mamulleri Sanayi AS
IS:PNSUT
Turkey TL9.48 Billion
Alterity Therapeutics Limited
F:PBN
Germany €2.65 Million

Liability Composition Analysis (2017–2024)

This chart breaks down DreamCIS Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see DreamCIS Inc asset portfolio.

Liquidity & Leverage Metrics

DreamCIS Inc Total Liabilities Ratios Explained

DreamCIS Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.72 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.39 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DreamCIS Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DreamCIS Inc (2017–2024)

The table below shows the annual total liabilities of DreamCIS Inc from 2017 to 2024.

Year Total Liabilities Change
2024-12-31 ₩50.58 Billion
≈ $34.28 Million
+59.57%
2023-12-31 ₩31.70 Billion
≈ $21.48 Million
+9.26%
2022-12-31 ₩29.01 Billion
≈ $19.66 Million
+54.92%
2021-12-31 ₩18.73 Billion
≈ $12.69 Million
+54.34%
2020-12-31 ₩12.13 Billion
≈ $8.22 Million
-14.99%
2019-12-31 ₩14.27 Billion
≈ $9.67 Million
+28.92%
2018-12-31 ₩11.07 Billion
≈ $7.50 Million
+3.25%
2017-12-31 ₩10.72 Billion
≈ $7.27 Million
--

About DreamCIS Inc

KQ:223250 Korea Medical Care Facilities
Market Cap
$65.32 Million
₩96.39 Billion KRW
Market Cap Rank
#20612 Global
#1129 in Korea
Share Price
₩4050.00
Change (1 day)
+2.14%
52-Week Range
₩2450.00 - ₩7690.00
All Time High
₩8112.50
About

DreamCIS, Inc. operates as a clinical research organization in South Korea. It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headqua… Read more